Tag: Prescription Drugs

Risk for COVID-19 hospitalization or death reduced for those who were severely or moderately immunocompromised

Real-world study shows greater reductions in HbA1c and body weight for patients with proportion of days covered ≥60 percent

Ten drugs have been chosen for price negotiations by the Centers for Medicare & Medicaid Services

Extended-release buprenorphine not cost-effective when transmucosal buprenorphine is available for treatment of OUD

No significant improvement in progression-free, overall survival seen with addition of lenalidomide to cediranib

Likelihood of experiencing a serious medical outcome or being admitted to a health care facility was increased for children younger than 6 years

Changes in office systolic BP of −14.1, −13.2, −6.9, and −4.1 mm Hg seen with 100, 50, 12.5 mg once daily of lorundrostat and placebo

Any β-blocker use cuts odds by nearly half, driven by nonselective β1-blockers

Combination of a patch and fast-acting nicotine replacement therapy also effective

Incident hypertension, statin use higher with tenofovir alafenamide fumarate compared with tenofovir disoproxil fumarate